Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,894
Closed -$166K 13819
2025
Q3
$166K Buy
+24,894
New +$168K ﹤0.01% 11180
2024
Q1
Sell
-20,380
Closed -$155K 13538
2023
Q4
$155K Buy
+20,380
New +$137K ﹤0.01% 10944
2023
Q2
Sell
-1,082
Closed -$19.1K 13312
2023
Q1
$19.1K Buy
1,082
+910
+529% +$46.9K ﹤0.01% 12067
2022
Q4
$8.96K Sell
172
-1,461
-89% -$106K ﹤0.01% 11950
2022
Q3
$137K Buy
1,633
+1,045
+178% +$139K ﹤0.01% 11370
2022
Q2
$86K Sell
588
-1,797
-75% -$262K ﹤0.01% 11613
2022
Q1
$368K Sell
2,385
-1,539
-39% -$342K ﹤0.01% 9750
2021
Q4
$1.08M Buy
3,924
+2,300
+142% +$1.06M ﹤0.01% 7097
2021
Q3
$1.06M Buy
+1,624
New +$1.43M ﹤0.01% 7405

Jeff Yass's NEUE Position: Q4 2025 in Review

Jeff Yass sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 24,894 shares — an estimated $166K sold.

Jeff Yass first reported a position in NEUE in Q3 2021 and held it in 9 quarters. The position peaked at $1.08M in Q4 2021. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.

  • Jeff Yass reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
  • Jeff Yass sold 24,894 NeueHealth shares in Q4 2025, an estimated $166K.
  • Jeff Yass first reported a position in NeueHealth in Q3 2021 and held it in 9 quarters.
  • Jeff Yass's NeueHealth position peaked at $1.08M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.